Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Akoya Biosciences

Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022

Upgrades

Benzinga · Nov 3, 2022

Where Akoya Biosciences Stands With Analysts

Akoya Biosciences (NASDAQ:AKYA) has observed the following analyst ratings within the last quarter:

Benzinga · May 9, 2022

Akoya Biosciences Earnings Preview

Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Akoya Biosciences will report an earnings per share (EPS) of $-0.39.

Benzinga · May 4, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Akoya Biosciences Earnings Perspective: Return On Capital Employed

Benzinga Pro data, Akoya Biosciences (NASDAQ:AKYA) reported Q4 sales of $16.16 million. Earnings fell to a loss of $17.67 million, resulting in a 52.13% decrease from last quarter.

Benzinga · Mar 16, 2022

Coverage From

Benzinga

People

William Blair

55 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Keysight Technologies

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.